Jorge Enrique Machado Alba
Biographic Data
| ID | 7503226 |
|---|---|
| NAME | Jorge Enrique Machado Alba |
| GIVEN NAMES | Jorge Enrique Machado |
| FAMILY NAME | Alba |
| SIGNATURE | ALBA J E M |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2007 |
| LATEST PUBLICATION YEAR | 2012 |
| H-INDEX | 0 |
Evolución del consumo de medicamentos de alto costo en Colombia
In Colombia a crisis has occurred in recent years due to the high spending generated by the most expensive drugs. The progressive growth of pharmaceutical spending is greater than the increased coverage by the country's health system. The Colombian health system should evaluate how much it is willing to pay for the most expensive drugs for some diseases and what strategies should be implemented to cover these expenses and thus guarantee access to…
Patrones de prescripción de antidiabéticos en un grupo de pacientes colombianos
There are significant differences in oral therapies prescribed for diabetes across the 19 cities studied, but overall, prescription patterns are appropriate. Educational strategies should be developed to address those prescribing practices that are not appropriate, and the clinical results of the medications studied should be explored
No prominent works on this page.
Patrones de prescripción de antidiabéticos en un grupo de pacientes colombianos
There are significant differences in oral therapies prescribed for diabetes across the 19 cities studied, but overall, prescription patterns are appropriate. Educational strategies should be developed to address those prescribing practices that are not appropriate, and the clinical results of the medications studied should be explored
Evolución del consumo de medicamentos de alto costo en Colombia
In Colombia a crisis has occurred in recent years due to the high spending generated by the most expensive drugs. The progressive growth of pharmaceutical spending is greater than the increased coverage by the country's health system. The Colombian health system should evaluate how much it is willing to pay for the most expensive drugs for some diseases and what strategies should be implemented to cover these expenses and thus guarantee access to…
Medication Adherence and Compliance (2 works) · Analysis of variance (1 work) · Chronic Disease Management Strategies (1 work) · Demography (1 work) · Demography (1 work) · Diabetes mellitus (1 work) · Diabetes, Cardiovascular Risks, and Lipoproteins (1 work) · Endocrinology (1 work) · Glibenclamide (1 work) · Humanities (1 work)